[HTML][HTML] Hypophysitis

A Prete, R Salvatori - 2018 - europepmc.org
Hypophysitis is an inflammation of the pituitary gland and is a rare cause of hypopituitarism.
It can be primary (idiopathic) or secondary to sella and parasellar lesions, systemic …

Neuroimaging of central diabetes insipidus—when, how and findings

NC Adams, TP Farrell, A O'shea, A O'Hare, J Thornton… - Neuroradiology, 2018 - Springer
Central or neurogenic diabetes insipidus (CDI) is due to deficient synthesis or secretion of
antidiuretic hormone (ADH), also known as arginine vasopressin peptide (AVP). It is …

High prevalence of weight gain in childhood brain tumor survivors and its association with hypothalamic-pituitary dysfunction

J van Schaik, IMAA van Roessel… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE Childhood brain tumor survivors (CBTS) are at risk for developing obesity, which
negatively influences cardiometabolic health. The prevalence of obesity in CBTS may have …

Guidelines for treatment and monitoring of adult survivors of pediatric brain tumors

AJ Janss, C Mazewski, B Patterson - Current Treatment Options in …, 2019 - Springer
Opinion statement Pathologies of pediatric brain tumors are more varied than those
diagnosed in adults and survival outcomes more optimistic. Therapies for pediatric brain …

The molecular basis of hypoprolactinaemia

BP Finn, MT Dattani - Reviews in Endocrine and Metabolic Disorders, 2024 - Springer
Hypoprolactinaemia is an endocrinopathy which is typically encountered as part of a
combined pituitary hormone deficiency picture. The vast majority of genetic causes identified …

Approach to the patient: management of pituitary hormone replacement through transition

M Cerbone, H Katugampola… - The Journal of …, 2022 - academic.oup.com
Hypopituitarism in childhood is a rare, complex disorder that can present with highly variable
phenotypes, which may continue into adult life. Pituitary deficits can evolve over time, with …

The function of adrenal glands in children and adolescents during and after oncological treatment

B Hull, A Wedrychowicz - Pediatric Endocrinology Diabetes and …, 2022 - termedia.pl
The purpose of this work was to present the current state of knowledge on the effects of
frequently used therapeutic forms, selected pharmacotherapy (including …

[HTML][HTML] Overview of European standard clinical practice recommendations for multidiscplinary teams involved in the treatment of central nervous system tumours in …

M Otth, K Scheinemann, T Ajithkumar, K Aquilina… - EJC Paediatric …, 2024 - Elsevier
Tumours of the central nervous system (CNS) represent the most common group of solid
tumours in children and adolescents up to the age of 18 years. They comprise several …

Neuroimaging of central diabetes insipidus

TP Farrell, NC Adams, S Looby - Handbook of clinical neurology, 2021 - Elsevier
Central diabetes insipidus (CDI) occurs secondary to deficient synthesis or secretion of
arginine vasopressin peptide from the hypothalamo–neurohypophyseal system (HNS). It is …

Endocrine effects of MEK and BRAF inhibitor therapy in paediatric patients: a tertiary centre experience

AHB Jalal, H Gunn, B Gunasekara, HW Gan - Journal of Neuro-Oncology, 2024 - Springer
Purpose BRAF and MEK inhibitors are used to treat a range of paediatric tumours including
low-grade gliomas. The ubiquitous nature of the BRAF/MAPK/MEK pathway means such …